Who is on it, and how far along Every drug ChEMBL records acting on this target, by the furthest stage it has reached for any use, coloured by modality.
How to read this Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.
Small molecule 2 Protein or peptide 1 Other 2 Approved3 Vancomycin Vancomycin SponsorReselute ModalitySmall molecule ActionInhibitor Open trials134 Dalbavancin Dalbavancin SponsorAbbVie ModalityProtein or peptide ActionInhibitor Open trials7 Oritavancin Oritavancin SponsorMelinta Therapeutics ModalitySmall molecule ActionInhibitor Open trials2 Phase 31 Teicoplanin Teicoplanin SponsorNovartis Pharmaceuticals ModalityOther ActionDisrupting agent Open trials9 Phase 21 Cefilavancin Cefilavancin SponsorTheravance Biopharma ModalityOther ActionInhibitor Open trials0
Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. 4 of 5 act as: Peptidoglycan inhibitor; the rest name their own mechanism. The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 24 in all, from ClinicalTrials.gov. Trial Drug Phase Status Lead sponsor First posted Primary Sclerosing Cholangitis After Liver Transplant With Oral Vancomycin Vancomycin Phase 1 Not yet recruiting Yael R. Nobel Nov 18, 2026 Ceftazidime Safety and Efficacy in the Prevention of Surgical Site Infections Vancomycin Phase 2 Enrolling by invitation University of Utah Nov 12, 2026 Local Antibiotic Delivery From an Intramedullary Nail After Surgical Treatment of Tibial Fractures at High Risk of Infection Vancomycin Not applicable Not yet recruiting Reselute, Inc. Nov 10, 2026 Safety, Dosage, and Microbiome Engraftment Study of MGT-006 for Ulcerative Colitis (ROOT Study) Vancomycin Phase 1 / Phase 2 Recruiting Metagen Therapeutics, Inc. Nov 3, 2026 Vancomycin Exposure and Biomarker Tracking Using Real-time Monitoring of Interstitial Fluid Vancomycin — Not yet recruiting Nutromics Oct 23, 2026 Rutin and Ascorbic Acid for Prevention of Vancomycin-Induced Nephrotoxicity in Adult Patients" - a Clinical Trial Protocol Evaluating Whether Combined Rutin/Vitamin C Supplementation Reduces Kidney Toxicity From Vancomycin, Compared to Vitamin C Alone and Control. Vancomycin Not applicable Enrolling by invitation Ain Shams University Oct 14, 2026 Optimised Dalbavancin Dosing for Serious Gram-Positive Bacterial Infections Dalbavancin — Not yet recruiting Kirby Institute Oct 5, 2026 A Phase 2b Study to Evaluate the Efficacy, Safety, and PK Profiles of TNP-2092 Administered Via IA Injection in PJI Participants Vancomycin Phase 2 Recruiting TenNor Therapeutics (Zhongshan) Limited Oct 5, 2026 Exploring the Combination of Intracalvariosseous and Intravenous Antibiotics for Moderate to Severe Bacterial Meningitis Vancomycin Not applicable Not yet recruiting yilong Wang Sep 17, 2026 Dalbavancin Therapy for Infective Endocarditis Dalbavancin Phase 3 Not yet recruiting Stefan Hagel Jul 13, 2026 Early Discontinuation of Antibiotics in Paediatric High-risk Febrile Neutropenia Teicoplanin Phase 4 Not yet recruiting Hospital Universitari Vall d'Hebron Research Institute May 15, 2026 Oritavancin for Treatment of Serious Cardiac Infections Oritavancin Phase 2 Not yet recruiting Kirby Institute Apr 24, 2026 Oritavancin for CIED Infections With MDR Gram-positive Cocci Oritavancin Not applicable Recruiting Medical University of Silesia Jun 10, 2025 Comparative Analysis of Nemonoxacin and Other Anti-methicillin Resistant Staphylococcus Aureus (Anti-MRSA) Antimicrobial Therapy in Patients With Complicated Skin and Soft Tissue Infections (cSSTI): a Retrospective Chart Review Study Teicoplanin — Active, not recruiting National Taiwan University Hospital May 6, 2025 Efficacy and Safety of Dalbavancin As Suppressive Therapy Dalbavancin — Recruiting Hospices Civils de Lyon Mar 28, 2025 Comparison of Efficacy and Safety of Ceftazidime Avibactam Versus Extended Infusions of High Dose Meropenem in Patients of ACLF With Nosocomial Infections. Teicoplanin Not applicable Recruiting Institute of Liver and Biliary Sciences, India Feb 10, 2025 A Prospective Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk Leukemia Dalbavancin Phase 1 Recruiting St. Jude Children's Research Hospital Feb 5, 2025 Teicoplanin Allergy Testing Using Autologous Serum (TATAS) Teicoplanin Not applicable Recruiting University Hospital Southampton NHS Foundation Trust Jan 31, 2025 Using a Population Pharmacokinetic Model to Estimate the Dosage of Teicoplanin in Patients With Hematologic Malignancy or Critical Illness Teicoplanin — Not yet recruiting National Taiwan University Hospital Nov 5, 2024 Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation (PADECMO) Teicoplanin Not applicable Recruiting University Hospital, Ghent May 23, 2024 Ampicillin and Ceftriaxone for the Treatment of Enterococcus Faecalis Infective Endocarditis. Dalbavancin, Teicoplanin Phase 4 Recruiting Fundación Pública Andaluza para la gestión de la Investigación en Sevilla May 21, 2024 Dalbavancin Versus Standard Antibiotic Therapy for Catheter-related Bloodstream Infections Due to Staphylococcus Aureus Dalbavancin Phase 3 Recruiting Assistance Publique - Hôpitaux de Paris Nov 11, 2021 Efficacy of Dalbavancin in Osteoarticular Infections Associated With Hip and Knee Replacements Dalbavancin Not applicable Active, not recruiting Centre Hospitalier Universitaire de Nice Sep 16, 2021 PRF With Topical Antibiotics or Antiseptics in Chronical Wounds Version 1.4 Teicoplanin Not applicable Recruiting Medical University of Vienna Jan 11, 2016
Show all 24Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL3041361 , ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov , checked daily; this page as of 2026-11-21. ChEMBL and Open Targets